View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2025-06-23 |
| Par Value | 1000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 800.17 |
| Coupon | 4 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 1747.732 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Baxalta Inc corporate medium term notes has a 4.00% fixed rate coupon paid on a semi-annual basis. It was issued on December 23, 2015 with an issue size of 1747.73 million USD and matures on June 23, 2025 with a last coupon date of December 23, 2024. |
Baxalta Inc, founded in 2015 and headquartered in Bannockburn, Illinois, is a biopharmaceutical company focused on developing and delivering innovative therapies for rare diseases and complex medical conditions. The company specializes in hematology, immunology, and oncology, offering a range of therapies, including significant advancements in treatments for bleeding disorders and immune deficiencies.